BIO-Europe Spring® Receives Unanimous Endorsement of Spanish Bio-Pharma Industry Registrations up 30 percent over last year’s event in Milan
Carlsbad, USA and Madrid, Spain, February 20, 2008: EBD Group today announced that registrations for BIO-Europe Spring 2008, April 7-9, 2008 in Palacio Municipal de Congresos, Madrid, Spain, are up 30 percent from last year’s highly successful inaugural event in Milan, Italy.
In addition, BIO-Europe Spring has received the unanimous backing of the Spanish Bio-Pharma Industry, including Almirall, Esteve, Grupo Uriach, Cellerix and the backing of local hosts of Madrid Biocluster, PromoMadrid, IMADE, Cámara de Madrid, Genoma España, Interes, Fundación para el Conocimiento madri+d and CEIM.
“The companies and research activities based around Madrid form the heart of Spain’s emerging biotechnology industry. Today, Madrid leads Spain with 27 percent of total biotech companies and, significantly, accounts for 45.2 percent of sales and 45.5 per cent of employment by biotech companies. PromoMadrid is very excited to be the host of the BIO-Europe Spring 2008 event, which will help illuminate the rapid progress of our industry, the undisputed quality of our science and the great potential for partnering with Spanish biotechs,” said Jesús Sainz, Chairman of PromoMadrid.
Overall, the number of biotech firms in Spain has doubled in the last six years to 150, half of which are focused on product discovery and development. There are over 500 enterprises in Spain that are engaged in the biotech arena, producing a turnover in excess of € 20,000 Million.
“The prosperity of the Spanish biotech industry requires forming collaborations
with firms from around the world and educating the biotech industry
on the many benefits of forming alliances with world-class companies
and research institutions in Spain,” said Dr. Josep Lamarca, Senior
Director of Corporate Development Licensing Projects, Almirall. “As
one of the largest stand-alone partnering conferences, BIOEurope Spring
in Madrid will enable the biotech industry elite to fully appreciate
the deal-making potential in Spain, as well as engage with potential
collaborators from across the biotechnology spectrum.” BIO-Europe Spring
utilizes partneringONE™, the industry’s most trusted and intuitive web-based
conference partnering system that is purpose-built to create and facilitate
connections among companies across entire
global industry value-chains.
“We look forward to a highly productive and exciting conference in Madrid,” said Carola Schropp, EBD Group’s managing director. “The success of BIO-Europe Spring among key pharma-biotech players is the powerful mix of “virtual” online collaboration with a stimulating physical event. Partnering in all its complexity, whether based on product licensing or a technology transfer, whether for a merger or acquisition, the process must start with a contact and targeting the right partners at the right time.”
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
BD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences at industry events.
Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com or contact:
Constantine Theodoropulos
EBD Group
+1 617 816 4637
ctheodoropulos@ebdgroup.com
